Cited by 961Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchExtracellular vesicles in disease

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.

Identification of preclinical Alzheimer's disease by a profile of pathogenic proteins in neurally derived blood exosomes: A case‐control study

Open access

Fiandaca, Massimo S., Kapogiannis, Dimitrios, Mapstone, Mark, Boxer, Adam, Eitan, Erez, Schwartz, Janice B., Abner, Erin L., Petersen, Ronald C., Federoff, Howard J., Miller, Bruce L., Goetzl, Edward J.·2015·Alzheimer's & Dementia

DOI 10.1016/j.jalz.2014.06.008PMC PMC4329112

Open this paper in CoChat — free account

Abstract

Background: Proteins pathogenic in Alzheimer's disease (AD) were extracted from neurally derived blood exosomes and quantified to develop biomarkers for the staging of sporadic AD. Methods: Blood exosomes obtained at one time‐point from patients with AD (n = 57) or frontotemporal dementia (FTD) (n = 16), and at two time‐points from others (n = 24) when cognitively normal and 1 to 10 years later when diagnosed with AD were enriched for neural sources by immunoabsorption. AD‐pathogenic exosomal proteins were extracted and quantified by enzyme‐linked immunosorbent assays. Results: Mean exosomal levels of total tau, P‐T181‐tau, P‐S396‐tau, and amyloid β 1–42 (Aβ1–42) for AD and levels of P‐T181‐tau and Aβ1–42 for FTD were significantly higher than for case‐controls. Step‐wise discriminant modeling incorporated P‐T181‐tau, P‐S396‐tau, and Aβ1–42 in AD, but only P‐T181‐tau in FTD. Classification of 96.4% of AD patients and 87.5% of FTD patients was correct. In 24 AD patients, exosomal levels of P‐S396‐tau, P‐T181‐tau, and Aβ1–42 were significantly higher than for controls both 1 to 10 years before and when diagnosed with AD. Conclusions: Levels of P‐S396‐tau, P‐T181‐tau, and Aβ1–42 in extracts of neurally derived blood exosomes predict the development of AD up to 10 years before clinical onset.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.jalz.2014.06.008

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease
Sperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., Iwatsubo, T., Jack, C. R., Kaye, J., Montine, T. J., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.003 · Cited by 7,155
Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia
Rascovsky, K., Hodges, J. R., Knopman, D., Mendez, M. F., Kramer, J. H., Neuhaus, J., van Swieten, J. C., Seelaar, H., Dopper, E. G. P., Onyike, C. U., et al. (2011) · Brain · doi:10.1093/brain/awr179 · Cited by 5,221
Self-citation
Classification of primary progressive aphasia and its variants
Gorno-Tempini, M. L., Hillis, A. E., Weintraub, S., Kertesz, A., Mendez, M., Cappa, S. F., Ogar, J. M., Rohrer, J. D., Black, S., Boeve, B. F., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e31821103e6 · Cited by 5,141
Self-citation
Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria
Dubois, B., Feldman, H. H., Jacova, C., DeKosky, S. T., Barberger-Gateau, P., Cummings, J., Delacourte, A., Galasko, D., Gauthier, S., Jicha, G., et al. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70178-3 · Cited by 4,411
Clinical and biomarker changes in dominantly inherited Alzheimer's disease
Bateman, R. J., Xiong, C., Benzinger, T. L. S., Fagan, A. M., Goate, A., Fox, N. C., Marcus, D. S., Cairns, N. J., Xie, X., Blazey, T. M., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1202753 · Cited by 3,814
Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study
Villemagne, V. L., Burnham, S., Bourgeat, P., Brown, B., Ellis, K. A., Salvado, O., Szoeke, C., Macaulay, S. L., Martins, R., Maruff, P., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70044-9 · Cited by 2,279
Alzheimer’s Dementia
Melnick, V. L., & Dubler, N. N. (1985) · Contemporary Issues in Biomedicine, Ethics, and Society · doi:10.1007/978-1-4612-5174-3 · Cited by 1,986
Alzheimer’s disease β-amyloid peptides are released in association with exosomes
Rajendran, L., Honsho, M., Zahn, T. R., Keller, P., Geiger, K. D., Verkade, P., & Simons, K. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603838103 · Cited by 1,343
Plasma phospholipids identify antecedent memory impairment in older adults
Mapstone, M. E., Cheema, A. K., Fiandaca, M. S., Zhong, X., Mhyre, T. R., MacArthur, L. H., Hall, W. J., Fisher, S. G., Peterson, D. R., Haley, J. M., et al. (2014) · Nature Medicine · doi:10.1038/nm.3466 · Cited by 1,060
Self-citation
Exosome-associated tau is secreted in tauopathy models and is selectively phosphorylated in cerebrospinal fluid in early Alzheimer disease
Saman, S., Kim, W., Raya, M., Visnick, Y., Miro, S., Saman, S., Jackson, B., McKee, A. C., Alvarez, V. E., Lee, N. C. Y., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.277061 · Cited by 985

Show all 31 references

Sorted by citations

Items 601–700 of 961

Mesoporous magnetic nanoparticles conjugated aptamers for exosomes capture and detection of Alzheimer's disease
Wang, G., Pan, Z., Zhu, X., Yang, R., Yang, R., Yang, T., Hu, D., Jing, A., & Liang, G. (2023) · Engineered Regeneration · doi:10.1016/j.engreg.2023.04.007 · Cited by 14
Exploring the significance of lipids in Alzheimer's disease and the potential of extracellular vesicles
Su, H., Masters, C. L., Bush, A. I., Barnham, K. J., Reid, G. E., & Vella, L. J. (2023) · PROTEOMICS · doi:10.1002/pmic.202300063 · Cited by 13
Cell-free RNA signatures predict Alzheimer’s disease
Cisterna‐García, A., Beric, A., Ali, M., Pardo, J. A., Chen, H., Fernández, M. V., Norton, J. B., Gentsch, J., Bergmann, K., Budde, J., et al. (2023) · iScience · doi:10.1016/j.isci.2023.108534 · Cited by 14
Communication between nonalcoholic fatty liver disease and atherosclerosis: Focusing on exosomes
Zhao, X., Kong, X., Cui, Z., Zhang, Z., Wang, M., Liu, G., Gao, H., Zhang, J., & Qin, W. (2024) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2024.106690 · Cited by 14
Exosomes in Vascular/Neurological Disorders and the Road Ahead
Alzahrani, F. A., Riza, Y. M., Eid, T. M., Almotairi, R., Scherschinski, L., Contreras, J., Nadeem, M., Perez, S. E., Raikwar, S. P., Jha, R. M., et al. (2024) · Cells · doi:10.3390/cells13080670 · Cited by 15
From understanding to action: Exploring molecular connections of Down syndrome to Alzheimer's disease for targeted therapeutic approach
Sukreet, S., Rafii, M. S., & Rissman, R. A. (2024) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12580 · Cited by 13
Extracellular vesicles and their diagnostic potential in amyotrophic lateral sclerosis
Roy, J. W., Saucier, D., O’Connell, C. M., & Morin, P. (2019) · Clinica Chimica Acta · doi:10.1016/j.cca.2019.07.012 · Cited by 15
Association between plasma exosome neurogranin and brain structure in patients with Alzheimer’s disease: a protocol study
He, M., Sun, L., Cao, W., Yin, C., Sun, W., Liu, P., Tan, L., Xu, Z., & Zhao, W. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-036990 · Cited by 14
Proteomics for comprehensive characterization of extracellular vesicles in neurodegenerative disease
Vinaiphat, A., & Sze, S. K. (2022) · Experimental Neurology · doi:10.1016/j.expneurol.2022.114149 · Cited by 14
Immuno-digital invasive cleavage assay for analyzing Alzheimer’s amyloid ß-bound extracellular vesicles
Yuyama, K., Sun, H., Igarashi, Y., Monde, K., Hirase, T., Nakayama, M., & Makino, Y. (2022) · Alzheimer s Research & Therapy · doi:10.1186/s13195-022-01073-w · Cited by 13
Extracellular Vesicles in Premature Aging and Diseases in Adulthood Due to Developmental Exposures
Pinson, M. R., Chung, D. D., Adams, A. M., Scopice, C., Payne, E. A., Sivakumar, M., & Miranda, R. C. (2021) · Aging and Disease · doi:10.14336/ad.2021.0322 · Cited by 15
Exosome: The “Off-the-Shelf” Cellular Nanocomponent as a Potential Pathogenic Agent, a Disease Biomarker, and Neurotherapeutics
Ghosh, S., & Ghosh, S. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.878058 · Cited by 13
Vesicular trafficking and cell-cell communication in neurodevelopment and neurodegeneration
Amin, S., & Taverna, E. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1600034 · Cited by 14
Hepatitis Viruses Control Host Immune Responses by Modifying the Exosomal Biogenesis Pathway and Cargo
Karamichali, E., Foka, P., Papadopoulou, G., Loukaki-Gkountara, D., Andresaki, K., Koskinas, J. S., & Georgopoulou, U. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810862 · Cited by 14
Extracellular Vesicles From Bone Marrow‐Derived Macrophages Enriched in ARG1 Enhance Microglial Phagocytosis and Haematoma Clearance Following Intracerebral Haemorrhage
Hu, L., Chen, Z., Lu, J., Jiang, S., Lin, H., Zhou, J., Wang, N., Ding, C., Ni, W., Peng, H., et al. (2025) · Journal of Extracellular Vesicles · doi:10.1002/jev2.70041 · Cited by 16
Tau Protein in Oral Mucosa and Cognitive State: A Cross-sectional Study
Arredondo, L. F., Aranda‐Romo, S., Rodríguez‐Leyva, I., Chi-Ahumada, É., Saikaly, S. K., Portales‐Pérez, D. P., González‐Amaro, R., Salgado‐Bustamante, M., Enríquez‐Macías, L., Eng, W., et al. (2017) · Frontiers in Neurology · doi:10.3389/fneur.2017.00554 · Cited by 13
BACE1 Translation: At the Crossroads Between Alzheimer’s Disease Neurodegeneration and Memory Consolidation
Guix, F. X., Sartório, C. L., & ILL‐Raga, G. (2019) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-180089 · Cited by 13
Exosomes in the Field of Neuroscience: A Scientometric Study and Visualization Analysis
Long, J., Zhang, Y., Liu, X., Pan, M., & Gao, Q. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.871491 · Cited by 13
Roles of Extracellular Vesicles in Multiple Sclerosis: From Pathogenesis to Potential Tools as Biomarkers and Therapeutics
Pistono, C., Osera, C., Cuccia, M., & Bergamaschi, R. (2023) · Sclerosis · doi:10.3390/sclerosis1020011 · Cited by 13
The incubation period of Alzheimer’s disease and the timing of tau versus amyloid misfolding and spreading within the brain
Goudsmit, J. (2016) · European Journal of Epidemiology · doi:10.1007/s10654-016-0144-8 · Cited by 13
Association of Transfusion With Risks of Dementia or Alzheimer’s Disease: A Population-Based Cohort Study
Lin, S.-Y., Hsu, W., Lin, C., Lin, C., Yeh, H., & Kao, C. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00571 · Cited by 13
Brain exosomes as minuscule information hub for Autism Spectrum Disorder
Dean, D. D., Agarwal, S., Muthuswamy, S., & Asim, A. (2021) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2021.2000395 · Cited by 13
Multifaceted roles of extracellular vesicles in the interplay of neuroinflammation and neurodegenerative diseases
Deng, Z., Chen, H., Chen, J., Du, Z., Zhou, W., & Yuan, Z. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2025.167960 · Cited by 14
Examination of the enrichment of neuronal extracellular vesicles from cell conditioned media and human plasma using an anti-NCAM immunocapture bead approach
Collier, M. E. W., Allcock, N., Sylvius, N. B., Cassidy, J., & Giorgini, F. (2025) · BMC Methods · doi:10.1186/s44330-025-00034-7 · Cited by 13
Exosomal Non-Coding RNAs as Potential Biomarkers for Alzheimer’s Disease: Advances and Perspectives in Translational Research
Titze-de-Almeida, S. S., Marina, C. L., Ramos, M. V., Silva, L. D. D. S., Brandão, P. R. D. P., Bispo, D. D. D. C., von Glehn, F., & Titze‐de‐Almeida, R. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178246 · Cited by 13
Potential of exosomes for targeted therapy in neuroinfectious disease management: crossing the blood–brain barrier
Bukke, S. P. N., Yadav, S., Prajapati, S., Rani, S. S., Reddy, M. S., Thalluri, C., Chettupalli, A. K., Goruntla, N., Pradeepkumar, B., Eftekhari, Z., et al. (2025) · Tissue Barriers · doi:10.1080/21688370.2025.2607157 · Cited by 12
Alzheimer's disease diagnosis by blood plasma molecular fluorescence spectroscopy (EEM)
Santos, R. F., Paraskevaidi, M., Mann, D. M. A., Allsop, D., Santos, M. C. D., Morais, C. L. M., & Lima, K. M. G. (2022) · Scientific Reports · doi:10.1038/s41598-022-20611-y · Cited by 14
Monitoring of Post-Brain Injuries By Measuring Plasma Levels of Neuron-Derived Extracellular Vesicles
Hotta, N., Tadokoro, T., Henry, J., Koga, D., Kawata, K., Ishida, H., Oguma, Y., Hirata, A., Mitsuhashi, M., & Yoshitani, K. (2022) · Biomarker Insights · doi:10.1177/11772719221128145 · Cited by 12
Adipocyte-Derived Small Extracellular Vesicles from Patients with Alzheimer Disease Carry miRNAs Predicted to Target the CREB Signaling Pathway in Neurons
Batabyal, R., Bansal, A., Cechinel, L. R., Authelet, K. J., Goldberg, M., Nadler, E. P., Keene, C. D., Jayadev, S., Domoto‐Reilly, K., Li, G., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241814024 · Cited by 13
Mechanical properties of blood exosomes and lipoproteins after the rat whole blood irradiation with X-rays in vitro explored by atomic force microscopy
Челнокова, И. А., Nikitina, I. A., & Starodubtseva, M. N. (2024) · Micron · doi:10.1016/j.micron.2024.103662 · Cited by 12
Comparison of plasma soluble and extracellular vesicles-associated biomarkers in Alzheimer’s disease patients and cognitively normal individuals
Boyer, E., Deltenre, L., Dourte, M., Colmant, L., Paître, E., Sleegers, K., Suelves, N., Hanseeuw, B. J., & Kienlen‐Campard, P. (2024) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01508-6 · Cited by 16
Prospects and challenges in using neuronal extracellular vesicles in biomarker research
Rocha, D. A. S., Santos, L. E., Fonseca, P. B. D., & Felice, F. G. D. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.13918 · Cited by 12
Profiling of microglial-originated microvesicles to unearthing their lurking potential as potent foreseeable biomarkers for the diagnosis of Alzheimer’s disease: A systematic review
Kanuri, S. H., & Sirrkay, P. J. (2024) · Brain Circulation · doi:10.4103/bc.bc_113_23 · Cited by 13
Biofluid biomarkers for Alzheimer’s disease: past, present, and future
An, C., Cai, H., Ren, Z., Fu, X., Quan, S., & Jia, L. (2024) · Medical Review · doi:10.1515/mr-2023-0071 · Cited by 14
Extracellular vesicle-packed microRNAs profiling in Alzheimer’s disease: The molecular intermediary between pathology and diagnosis
Arif, S., Qazi, T. J., Quan, Z., Ni, J., Li, Z., Qiu, Y., & Qing, H. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102614 · Cited by 13
PET imaging of kappa opioid receptors and receptor expression quantified in neuron-derived extracellular vesicles in socially housed female and male cynomolgus macaques
Johnson, B., Kumar, A., Su, Y., Singh, S., Sai, K. K. S., Nader, S. H., Li, S., Reboussin, B. A., Huang, Y. H., Deep, G., et al. (2022) · Neuropsychopharmacology · doi:10.1038/s41386-022-01444-9 · Cited by 12
Variant biomarker discovery using mass spectrometry-based proteogenomics
Reilly, L., Seddighi, S., Singleton, A., Cookson, M., Ward, M. E., & Qi, Y. A. (2023) · Frontiers in Aging · doi:10.3389/fragi.2023.1191993 · Cited by 13
Prospects for the Use of Small Extracellular Vesicles as a Transport Vehicle through the Blood–Brain Barrier
Хаспеков, Л. Г., & Yakovlev, A. A. (2023) · Neurochemical Journal · doi:10.1134/s1819712423010087 · Cited by 12
Glutamine Supplementation Preserves Glutamatergic Neuronal Activity in the Infralimbic Cortex, Which Delays the Onset of Mild Cognitive Impairment in 3×Tg-AD Female Mice
Baek, J. H., Kang, J. S., Song, M., Lee, D., & Kim, H. J. (2023) · Nutrients · doi:10.3390/nu15122794 · Cited by 13
Proteomic and epigenomic markers of sepsis-induced delirium (SID)
Sfera, A., Price, A. I., Gradini, R., Cummings, M. A., & Osorio, C. P. (2015) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2015.00059 · Cited by 14
Advancing medicine for Alzheimer’s disease: A plasma neural exosome platform
Goetzl, E. J. (2020) · The FASEB Journal · doi:10.1096/fj.202001655 · Cited by 12
Self-citation
New Insights Regarding Diagnosis and Medication for Schizophrenia Based on Neuronal Synapse–Microglia Interaction
Izuo, N., & Nitta, A. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11050371 · Cited by 14
Distribution of microRNA profiles in pre-clinical and clinical forms of murine and human prion disease
Cheng, L., Quek, C. Y. J., Li, X., Bellingham, S. A., Ellett, L. J., Shambrook, M., Zafar, S., Zerr, I., Lawson, V., & Hill, A. F. (2021) · Communications Biology · doi:10.1038/s42003-021-01868-x · Cited by 12
The Multifaceted Role of Extracellular Vesicles in Alzheimer's Disease
Conceição, A. R., Marinatto, J., Pinheiro, L. S., Rody, T., & Felice, F. G. D. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70209 · Cited by 15
Exosomes in Alzheimer’s disease: From pathogenesis to therapeutics—A comprehensive review of diagnostic and drug delivery applications
Shahlaei, M., Afkhami, H., Ahmadieh-Yazdi, A., Mirmazloumi, S. H., Sahraei, S. S., Akbari, M., Yang, P., Manoochehri, H., Tanzadehpanah, H., Mahaki, H., et al. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118548 · Cited by 11
Extracellular Vesicle‐Derived microRNAs as Fluid Biomarkers in Neurodegenerative Diseases: A Systematic Review
Zaman, A., Drake, S., & Fournier, A. E. (2026) · Journal of Neurochemistry · doi:10.1111/jnc.70323 · Cited by 14
Biofluid Detection of Pathological α -Synuclein in the Prodromal Phase of Synucleinopathies
Kluge, A., & Iranzo, Á. (2024) · Journal of Parkinson s Disease · doi:10.3233/jpd-230429 · Cited by 12
Mesenchymal Stem Cell-Derived Extracellular Vesicles for Regenerative Applications and Radiotherapy
Wang, N., Ma, F., Song, H., He, N., Zhang, H., Li, J., Liu, Q., & Xu, C. (2025) · Cell Transplantation · doi:10.1177/09636897241311019 · Cited by 11
Circulating Biomarkers for the Early Diagnosis of Alzheimer’s Disease
Nunkoo, V. S., Jurcău, A., Les, M., Cristian, A., Militaru, M., Marge, C., Iovanovici, D. C., & Jurcău, M. C. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26157268 · Cited by 13
Integrated Multiomics Analysis of Salivary Exosomes to Identify Biomarkers Associated with Changes in Mood States and Fatigue
Cohn, W., Zhu, C., Campagna, J. J., Bilousova, T. V., Spilman, P. R., Teter, B., Li, F., Guo, R., Elashoff, D. A., Cole, G. M., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23095257 · Cited by 11
The Fate of Tau Aggregates Between Clearance and Transmission
Seitkazina, A., Kim, K. H., Fagan, E., Sung, Y., Kim, Y. K., & Lim, S. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.932541 · Cited by 10
Biomarkers for predicting disease course in Sanfilippo syndrome: An urgent unmet need in childhood‐onset dementia
Winner, L. K., Rogers, M., Snel, M. F., & Hemsley, K. M. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15891 · Cited by 11
Nano-Brush Structure for Rapid Label-Free Differentiation of Alzheimer’s Disease Stages and Direct Capture of Neuron-Derived Exosomes from Human Blood Plasma
Lin, S.-P., Lee, W.-J., Sun, M.-C., Yang, Y.-H., Vinzons, L. U., Lin, Y.-M., & Wei, Y.-T. (2023) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.3c12766 · Cited by 11
Antibody biomarker for de novo Parkinson disease: attempted validation
Feng, N., Simanski, S., Islam, K., Hynan, L. S., Kodadek, T. J., & German, D. C. (2018) · npj Parkinson s Disease · doi:10.1038/s41531-018-0064-2 · Cited by 11
Plasma Small Extracellular Vesicles with Complement Alterations in GRN/C9orf72 and Sporadic Frontotemporal Lobar Degeneration
Bellini, S., Saraceno, C., Benussi, L., Squitti, R., Cimini, S., Ricci, M., Canafoglia, L., Coppola, C., Puoti, G., Ferrari, C., et al. (2022) · Cells · doi:10.3390/cells11030488 · Cited by 11
Engineered extracellular vesicles (EVs): Promising diagnostic/therapeutic tools for pediatric high-grade glioma
Lyu, Y., Guo, Y., Okeoma, C. M., Yan, Z., Hu, N., Li, Z., Zhou, S., Zhao, X., Li, J., & Wang, X. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114630 · Cited by 11
Extracellular Vesicles in Alzheimer’s Disease: Dual Roles in Pathogenesis, Promising Avenues for Diagnosis and Therapy
Li, F., Wu, L., Feng, X., Li, Y., & Fan, H. (2026) · Pharmaceutics · doi:10.3390/pharmaceutics18010070 · Cited by 10
Extracellular vesicles as next-generation therapeutics and biomarkers in amyloidosis: a new frontier
Phan, T. H., & Reed, J. H. (2024) · Frontiers in Biomaterials Science · doi:10.3389/fbiom.2023.1343658 · Cited by 10
High fat diet affects the hippocampal expression of miRNAs targeting brain plasticity-related genes
Spinelli, M., Spallotta, F., Cencioni, C., Natale, F., Re, A., Dellaria, A., Farsetti, A., Fusco, S., & Grassi, C. (2024) · Scientific Reports · doi:10.1038/s41598-024-69707-7 · Cited by 10
The role of microglia in the prion-like transmission of protein aggregates in neurodegeneration
Öztürk, M. M., Emgård, J., García‐Revilla, J., Fernández‐Calle, R., Yang, Y., Deierborg, T., & Roos, T. T. (2025) · Brain Communications · doi:10.1093/braincomms/fcaf087 · Cited by 14
Advancing Alzheimer’s disease therapy through engineered exosomal Macromolecules
Jain, S., Murmu, A., & Chauhan, A. (2025) · Brain Research · doi:10.1016/j.brainres.2025.149590 · Cited by 10
Exploring Exosome-Based Approaches for Early Diagnosis and Treatment of Neurodegenerative Diseases
Varshney, V., Gabble, B. C., Bishoyi, A. K., Varma, P., Qahtan, S. A., Kashyap, A., Panigrahi, R., Nathiya, D., & Chauhan, A. S. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05026-w · Cited by 10
Potential modulation of microglial ferroptosis by Linggui Zhugan decoction in Alzheimer's disease through IL-17 and TNF pathways
Tang, P., Zhao, D., Lin, H., Li, X., Shi, C., Li, P., & Chen, H. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.115489 · Cited by 11
Microglial Extracellular Vesicles as Modulators of Brain Microenvironment in Glioma
Catalano, M., Serpe, C., & Limatola, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113165 · Cited by 11
Intrinsic factors behind long‐COVID: I. Prevalence of the extracellular vesicles
El‐Maradny, Y. A., Rubio‐Casillas, A., Uversky, V. N., & Redwan, E. M. M. M. (2023) · Journal of Cellular Biochemistry · doi:10.1002/jcb.30415 · Cited by 9
Neuronally enriched microvesicle RNAs are differentially expressed in the serums of Parkinson’s patients
Aguilar, M. A., Ebanks, S., Markus, H., Lewis, M. M., Midya, V., Vrana, K. E., Huang, X., Hall, M. A., & Kawasawa, Y. I. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1145923 · Cited by 10
CSF Extracellular Vesicle Aβ42 and Tau/Aβ42 Ratio Are Associated with Cognitive Impairment in Older People with HIV
Guha, D., Misra, V., Chettimada, S., Yin, J., & Gabuzda, D. H. (2023) · Viruses · doi:10.3390/v16010072 · Cited by 11
Precision Medicine: Role of Biomarkers in Early Prediction and Diagnosis of Alzheimer’s Disease
Shen, L., Xia, S., Zhang, H., Yao, F., Liu, X., Zhao, Y., Ying, M., Iqbal, J., & Liu, Q. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.82035 · Cited by 9
Emerging therapeutic roles of exosomes in HIV-1 infection
Pang, S.-W., & Teow, S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816053-4.00007-9 · Cited by 10
The future of quantum dot fluorescent labelling of extracellular vesicles for biomedical applications
Goreham, R. V., Ayed, Z., Amin, Z. M., & Dobhal, G. S. (2020) · Nano Futures · doi:10.1088/2399-1984/ab8bca · Cited by 10
Extracellular Vesicles in Neurological Disorders
Mazurskyy, A., & Howitt, J. A. (2021) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-030-67171-6_16 · Cited by 10
An Update on Peripheral Blood Extracellular Vesicles as Biomarkers for Parkinson's Disease Diagnosis
Wang, K., Shen, J., & Xu, Y. C. (2022) · Neuroscience · doi:10.1016/j.neuroscience.2022.11.017 · Cited by 10
The Biology, Pathological Roles of Exosomes and Their Clinical Application in Parkinson’s Disease
Huang, J., Yuan, X., Chen, L., Hu, B., Wang, H., & Huang, W. (2023) · Neuroscience · doi:10.1016/j.neuroscience.2023.09.001 · Cited by 9
Unlocking the potential of circulating small extracellular vesicles in neurodegenerative disease through targeted biomarkers and advancements in biosensing
Abdullah, S. A., Cocklereece, I., & Dellinger, K. (2024) · Exploration of BioMat-X · doi:10.37349/ebmx.2024.00008 · Cited by 10
α‐Synuclein species in plasma neuron‐derived extracellular vesicles as biomarkers for iRBD
Wang, X., Zheng, Y., Cai, H., Kou, W., Yang, C., Li, S., Zhu, B., Wu, J., Zhang, N., Feng, T., et al. (2024) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.52200 · Cited by 9
Bridging brain and blood: a prospective view on neuroimaging-exosome correlations in HIV-associated neurocognitive disorders
Luo, H., Chen, J. M., Liu, J., Wang, W., Hou, C., Jiang, X., Ma, J., Xu, F., Aili, X., Zhou, Z., et al. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2024.1479272 · Cited by 9
Metabolomic and Proteomic Profiling of Serum-Derived Extracellular Vesicles from Early-Stage Amyotrophic Lateral Sclerosis Patients
Ojaimi, Y. A., Vallet, N., Dangoumau, A., Lanznaster, D., Bruno, C., Lefèvre, A., Osman, S., Dupuy, C., Emond, P., Vourc’h, P., et al. (2025) · Journal of Molecular Neuroscience · doi:10.1007/s12031-025-02315-w · Cited by 9
A multi-target therapeutic framework for Alzheimer’s disease: an integrative mechanistic review
Bajinka, O., Jallow, L., & Ozdemir, G. (2026) · Neuroscience · doi:10.1016/j.neuroscience.2026.01.010 · Cited by 10
Tissue‐Specific Extracellular Vesicles Enriched From Circulation: Exploring the Liquid Biopsy Perspective
Pierri, B., Eitan, E., Witwer, K. W., Ré, D. B., Baccarelli, A., & Wu, H. (2026) · Journal of Extracellular Biology · doi:10.1002/jex2.70106 · Cited by 10
Self-citation
The Dual Role of Extracellular Vesicles in Aging and Age-Related Diseases: Pathophysiology and Therapeutic Potential
Zhu, Y., Fang, X., Zhang, S., Liao, Y., Lin, H., Chen, P., Yang, M., Huang, J. J., & Wang, X. (2026) · International Journal of Nanomedicine · doi:10.2147/ijn.s589123 · Cited by 14
Cell ageing: a flourishing field for neurodegenerative diseases
Brites, D. M. T. O. (2015) · AIMS molecular science · doi:10.3934/molsci.2015.3.225 · Cited by 10
Quantification of placental extracellular vesicles in different pregnancy status via single particle analysis method
Li, Z., Tao, M., Huang, M. J., Pan, W., Huang, Q., Wang, P., Zhang, Y., Situ, B., & Zheng, L. (2022) · Clinica Chimica Acta · doi:10.1016/j.cca.2022.12.021 · Cited by 9
Means, not ends.
Plutchak, T. S. (2004) · PubMed Central · Cited by 9
Therapeutic and diagnostic potential of extracellular vesicles in amyotrophic lateral sclerosis
Ellison, T. J., Stice, S. L., & Yao, Y. (2022) · Extracellular Vesicle · doi:10.1016/j.vesic.2022.100019 · Cited by 8
Fourier Transform Infrared Spectroscopy Analysis as a Tool to Address Aβ Impact on Extracellular Vesicles
Vaz, M., Martins, T. S., Leandro, K., de Almeida, L. P., Silva, O. A. B. D. C. E., Nunes, A., & Henriques, A. G. (2025) · Molecules · doi:10.3390/molecules30020258 · Cited by 8
Regulatory Roles of Exosomes in Aging and Aging-Related Diseases
Xiao, N., Li, Q., Liang, G., Qian, Z., Lin, Y., Zhang, H., Fu, Y., Yang, X. M., Zhang, C., Yang, J., et al. (2025) · Biogerontology · doi:10.1007/s10522-025-10200-7 · Cited by 8
Sensitive Detection of Exosomal Biomarkers via a Drop-Shaped Porous Microfluidic Chip for Potential Diagnosis of Alzheimer’s Disease
Xu, H., Zhang, Y., Shen, L., Yu, S., Li, C., Zeng, X., Liu, Q., & Ye, B. (2025) · Analytical Chemistry · doi:10.1021/acs.analchem.5c02003 · Cited by 8
Neuronal Enriched Extracellular Vesicle miR-122-5p as a Potential Biomarker for Alzheimer’s Disease
Subasinghe, K., Hall, C. L., Rowe, M., Zhou, Z., Barber, R. C., & Phillips, N. (2025) · Cells · doi:10.3390/cells14221784 · Cited by 9
A colorimetric and surface-enhanced Raman scattering dual-readout lateral flow assay improves the accuracy of early diagnosis of Alzheimer's disease by simultaneously detecting Aβ42 oligomers and phosphorylated tau
Zhang, L., Du, X., Zhang, T., Chen, Q., Zhang, Q., Su, Y., Zhang, M., & Luo, H. (2026) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2025.139417 · Cited by 8
On the other end of the line: Extracellular vesicle-mediated communication in glaucoma
Lucci, C., & Groef, L. D. (2023) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2023.1148956 · Cited by 9
The Adult Neurogenesis Theory of Alzheimer’s Disease
Abbate, C. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-221279 · Cited by 11
Brain-Derived Exosomal miRNA Profiles upon Experimental SAE Rats and Their Comparison with Peripheral Exosomes
Xiao, Q., Yan, X., Sun, Y., Tang, Y., Hou, R., Pan, X., & Zhu, X. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03569-4 · Cited by 9
The Potency of Biomarkers for the Diagnosis and Treatment of Parkinson's Disease and Alzheimer's Disease
Shahraki, M. S., Sourani, Z., Behdarvand, F., Mousavi, M. M., & Shirian, S. (2022) · The Neuroscience Journal of Shefaye Khatam · doi:10.61186/shefa.10.2.91 · Cited by 8
Simultaneous isolation of intact brain cells and cell-specific extracellular vesicles from cryopreserved Alzheimer’s disease cortex
Melnik, M., Miyoshi, E., Ma, R., Corrada, M. M., Kawas, C. H., Bohannan, R. C., Caraway, C. A., Miller, C. A., Hinman, J. D., John, V., et al. (2024) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2024.110137 · Cited by 8
The Role of Exosomes in the Pathogenesis, Diagnosis, and Treatment of Parkinson's and Alzheimer's Diseases
Moradi, H. R., Abdollahinezhad, S., & Heydarian, S. (2024) · The Neuroscience Journal of Shefaye Khatam · doi:10.61186/shefa.12.2.87 · Cited by 8
Biomarcadores en la enfermedad de Alzheimer
Janeiro, M. H., Ardanaz, C. G., Sola-Sevilla, N., Dong, J., Cortés-Erice, M., Solas, M., Puerta, E., & Ramírez, M. J. (2021) · Advances in Laboratory Medicine / Avances en Medicina de Laboratorio · doi:10.1515/almed-2020-0109 · Cited by 26
Levels of Receptor for Advanced Glycation End Products and Glyoxalase-1 in the Total Circulating Extracellular Vesicles from Mild Cognitive Impairment and Different Stages of Alzheimer’s Disease Patients
Haddad, M., Perrotte, M., Khedher, M. R. B., Madec, E., Page, A. Y. L., Fülöp, T., & Ramassamy, C. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210441 · Cited by 10
Dual action of exosomes derived from in vitro Aβ toxicity model: The role of age for pathological response
Beker, M., GÜnay, N., Johnson, B. S., Cakmak, R. K., Ercin, N., Altıntaş, M. Ö., Altunay, S., Beker, M. Ç., Sari, D., & Kılıç, Ü. (2022) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2022.104874 · Cited by 8
Shotgun Proteomic Profiling of Bloodborne Nanoscale Extracellular Vesicles
Heinzelman, P., Powers, D. N., Wohlschlegel, J. A., & John, V. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8935-5_32 · Cited by 8
Extracellular vesicles in neurodegenerative disorders
Mäger, I., Willms, E., Bonner, S. E., Hill, A. F., & Wood, M. J. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816053-4.00012-2 · Cited by 8

Authors: Fiandaca, M. S., Kapogiannis, D., Mapstone, M., Boxer, A., Eitan, E., Schwartz, J. B., Abner, E. L., Petersen, R. C., Federoff, H. J., Miller, B. L., & Goetzl, E. J.
Affiliations: Georgetown University Medical Center (US)
National Institute on Aging (US)
University of Rochester Medicine (US)
University of California San Francisco Medical Center (US)
University of Kentucky (US)
Mayo Clinic (US)
Corresponding author: Goetzl, Edward J.
ORCID: Fiandaca, Massimo S.
Kapogiannis, Dimitrios
Mapstone, Mark
Boxer, Adam
Eitan, Erez
Schwartz, Janice B.
Abner, Erin L.
Petersen, Ronald C.
Federoff, Howard J.
Miller, Bruce L.
Goetzl, Edward J.
Venue: Alzheimer's & Dementia
Publisher: Wiley
Published: 2014-08-14
Volume: 11
Issue: 6
Pages: 600
ISSN: 1552-5260 (ISSN-L)
1552-5279
DOI: 10.1016/j.jalz.2014.06.008
PMC: PMC4329112
OpenAlex: W1995903088
Cited by: 959
References: 31
Citations by year: 2026: 77 · 2025: 91 · 2024: 109 · 2023: 86 · 2022: 115 · 2021: 106 · 2020: 105 · 2019: 93 · 2018: 46 · 2017: 50 · 2016: 50 · 2015: 24 · 2014: 3
FWCI: 28.15
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor)
Locations: Alzheimer s & Dementia (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
eScholarship (California Digital Library) (submittedVersion)
Funders: National Institute on Aging (NIA RO1AG030753)
National Institutes of Health (UK ADC P30 AG028383)
Genentech
Alzheimer's Association
Association for Frontotemporal Degeneration
Alzheimer's Drug Discovery Foundation
Pfizer
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
Keywords: preclinical Alzheimer's disease, blood exosomes
MeSH terms: Aged, Aged, 80 and over, Alzheimer Disease, Cross-Sectional Studies, Enzyme-Linked Immunosorbent Assay, Female, Humans, Male, Middle Aged, Peptide Fragments, Phosphorylation, Retrospective Studies, Severity of Illness Index, Time Factors, Biomarkers, Discriminant Analysis, Case-Control Studies, Amyloid beta-Peptides, tau Proteins, Exosomes, Frontotemporal Dementia, Prodromal Symptoms

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Identification of preclinical Alzheimer's disease by a profile of pathogenic proteins in neurally derived blood exosomes: A case‐control study

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks